Correlation Between Dianthus Therapeutics and Burning Rock

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Burning Rock at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Burning Rock into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and Burning Rock Biotech, you can compare the effects of market volatilities on Dianthus Therapeutics and Burning Rock and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Burning Rock. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Burning Rock.

Diversification Opportunities for Dianthus Therapeutics and Burning Rock

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Dianthus and Burning is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Burning Rock Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Burning Rock Biotech and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Burning Rock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Burning Rock Biotech has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Burning Rock go up and down completely randomly.

Pair Corralation between Dianthus Therapeutics and Burning Rock

Given the investment horizon of 90 days Dianthus Therapeutics is expected to under-perform the Burning Rock. But the stock apears to be less risky and, when comparing its historical volatility, Dianthus Therapeutics is 2.29 times less risky than Burning Rock. The stock trades about -0.04 of its potential returns per unit of risk. The Burning Rock Biotech is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  500.00  in Burning Rock Biotech on September 3, 2024 and sell it today you would earn a total of  116.00  from holding Burning Rock Biotech or generate 23.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Dianthus Therapeutics  vs.  Burning Rock Biotech

 Performance 
       Timeline  
Dianthus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
Burning Rock Biotech 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Burning Rock Biotech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Burning Rock reported solid returns over the last few months and may actually be approaching a breakup point.

Dianthus Therapeutics and Burning Rock Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dianthus Therapeutics and Burning Rock

The main advantage of trading using opposite Dianthus Therapeutics and Burning Rock positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Burning Rock can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burning Rock will offset losses from the drop in Burning Rock's long position.
The idea behind Dianthus Therapeutics and Burning Rock Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format